pharmacotherapeutic classification:
Gastro-Entero-Hepatology : Primary biliary cirrhosis ( Ursodeoxycholic acid )
Metabolism - Diabetes - Nutrition - Mucoviscidosis : Liver damage: ursodeoxycholic acid ( Cholelithiasis: bile acid )
Metabolism - Diabetes - Nutrition - Mucoviscidosis : Liver damage: ursodeoxycholic acid ( Cholelithiasis: bile acid )
ATC classification:DIGESTIVE TRACT AND METABOLISM : HEPATIC AND BILIARY THERAPY - BILIARY THERAPY : BILE ACIDS AND DERIVATIVES ( URSODESOXYCHOLIC ACID )
Excipients:
corn starch , colloidal anhydrous silica , povidone , sodium lauryl sulfate , magnesium stearate
film coating: hypromellose , propylene glycol
colorant (film coating): titanium dioxide
Excipients with known effect :
NTE without threshold dose: anhydrous glucose
